Schedule (route) |
Endpoint |
Vehicle |
Dose |
Treated/Control (%) |
Observations |
Q01DX009 (ip) |
median survival time |
saline |
32.0 mg/kg/injection |
97.0 |
Antitumor endpoint evaluated on day 30; 05/05 animals surviving on tox evaluation day (usually day 5) |
Q01DX009 (ip) |
median survival time |
saline |
64.0 mg/kg/injection |
106.0 |
Antitumor endpoint evaluated on day 30; 05/05 animals surviving on tox evaluation day (usually day 5) |
Q01DX009 (ip) |
median survival time |
saline |
128.0 mg/kg/injection |
95.0 |
Antitumor endpoint evaluated on day 30; 05/05 animals surviving on tox evaluation day (usually day 5) |
Q01DX009 (ip) |
median survival time |
saline |
256.0 mg/kg/injection |
125.0 |
Antitumor endpoint evaluated on day 30; 05/05 animals surviving on tox evaluation day (usually day 5) |